Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 2007 2019

Filtrer
Konferenceabstrakt i tidsskrift
2019

Natural killer cells and treatment effect in recurrent ovarian cancer

Henriksen, J. R., Nederby, L., Donskov, F., Jakobsen, A., Adimi, P., Waldstrøm, M. & Dahl Steffensen, K., 20. sep. 2019, I : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 29, Suppl. 3, s. A33 1 s., 59.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Åben adgang

Prognostic impact of tumor infiltrating natural killer cells in ovarian carcinoma

Bidragets oversatte titel: Den prognostiske betydning af tumorinfiltrerende NK celler i æggestokkræftHenriksen, J. R., Donskov, F., Waldstrøm, M., Braad Petersen, C., Jakobsen, A. & Dahl Steffensen, K., 19. sep. 2019, I : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 29, Suppl. 3, s. A3 1 s., 4.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Åben adgang
2018

HOXA9 methylation in circulating tumor DNA as a prognostic biomarker in BRCA-mutated ovarian cancer patients treated with PARP inhibitor

Rusan, M., Andersen, R. F., Jakobsen, A. & Dahl Steffensen, K., 20. okt. 2018, I : Annals of Oncology. 29, Suppl. 8, 1 s., 954P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Åben adgang
Ovarian Neoplasms
DNA
Neoplasms
Disease-Free Survival
Poly(ADP-ribose) Polymerase Inhibitors
2017

Can postponement of death be used in shared decision making in patients treated with adjuvant chemotherapy?

Trabjerg, N. D., Hansen, T. F., Dahl Steffensen, K., Jakobsen, A. & Jensen, L. H., 8. sep. 2017, I : Annals of Oncology. 28, Suppl. 5, s. 561-562 1598P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Monitoring the effect of cytostatic treatment by immune activity

Hansen, T. F., Bechmann, T., Jacobsen, E. H., Zedan, A., Mejlholm, I., Henriksen, J. R., Dahl Steffensen, K., Brenner Thomsen, C. E., Raunkilde Larsen, L., Jensen, L. H. & Jakobsen, A., 8. sep. 2017, I : Annals of Oncology. 28, Suppl. 5, s. 578 1 s., 1644P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Oncological Management and Pregnancy Outcomes in Women Diagnosed With Cancer During Pregnancy: A 20-Year International Cohort Study of 1170 Patients

Verheecke, M., Van Calsteren, K., Fruscio, R., Lok, C. A., Zola, P., Ottevanger, P. B., Peccatori, F. A., Dahl Steffensen, K., Han, S. N. & Amant, F., 6. nov. 2017, I : International Journal of Gynecological Cancer. 27, Suppl. 4

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Åben adgang
2014

Matched cohort study on patients with cervical cancer diagnosed during pregnancy

Amant, F., Uzan, C., Han, S. N., Fruscio, R., Dahl Steffensen, K., Škultéty, J., Giuliani, D., Mephon, A., Rouzier, R., Witteveen, P., Locatelli, A., Rob, L. & Halaska, M. J., 2014, I : Annals of Oncology. 25, 4 (Supplement), s. iv320 1 s., 925P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Sentinel lymph node biopsy for breast cancer treatment during pregnancy: On behalf of the International Network of Cancer, Infertility and Pregnancy (INCIP) and the German Breast Group (GBG)

Han, S. N., Amant, F., Sangalli, C., Loibl, S., Gheysens, O., Lok, C. A. R., Dahl Steffensen, K., Halaska, M. J., Peccatori, F. A. & Gentilini, O., 2014, I : Annals of Oncology. 25, 4 (Supplement), 1 s., 266PD_PR.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Unplanned pregnancy during cancer treatment - on behalf of the International Network of Cancer, Infertility and Pregnancy (INCIP)

van Peer, S., Han, S. N., Dahl Steffensen, K., Halaska, M. J., Gziri, M. M., van Calsteren, K. & Amant, F., 2014, I : Annals of Oncology. 25, 4 (Supplement), 1527P_PR.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

2011

Improved classification of epithelial ovarian cancer into type 1 and type 2 tumors: Results of three Danish cohorts

Dahl Steffensen, K., Waldstrøm, M., Grove, A., Lund, B., Pallisgaard, N. & Jakobsen, A., sep. 2011, I : International Journal of Gynecological Cancer. 21, Suppl 3

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

2010

Panitumumab and pegylated liposomal doxorubicin to platinum-resistant epithelial ovarian cancer with KRAS wild-type: An ongoing, nonrandomized, multicenter, phase II trial

Dahl Steffensen, K., Waldstrøm, M., Lund, B., Bergfeldt, K., Keldsen, N., Marth, C., Vergote, IB. & Jakobsen, A., 2010, I : Journal of Clinical Oncology. 28:15s, 2010 (suppl; abstr TPS254), suppl, s. TPS254

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Platinum
Ovarian Neoplasms
Epidermal Growth Factor Receptor
Neoplasms
Topotecan
2007

COX2 expression and relation to long-term survival in epithelial ovarian cancer

Dahl Steffensen, K., Waldstrøm, M., Jeppesen, U., Brandslund, I. & Jakobsen, A., 2007, I : Acta Pathologica Microbiologica et Immunologica Scandinavica. 115, 3, s. 277

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review